Biomea Fusion (NASDAQ:BMEA) Rating Increased to Strong-Buy at EF Hutton Acquisition Co. I
Biomea Fusion (NASDAQ:BMEA – Get Free Report) was upgraded by equities research analysts at EF Hutton Acquisition Co. I to a “strong-buy” rating in a research report issued to clients and investors on Wednesday, Zacks.com reports. Several other equities analysts have also recently issued reports on the company. Scotiabank boosted their target price on Biomea […]
More Stories
Bone Biologics Co. (NASDAQ:BBLG) Short Interest Up 1,128.9% in September
Bone Biologics Co. (NASDAQ:BBLG – Get Free Report) saw a significant growth in short interest in the month of September....
Bridges Capital Tactical ETF (NASDAQ:BDGS) Short Interest Update
Bridges Capital Tactical ETF (NASDAQ:BDGS – Get Free Report) was the recipient of a large growth in short interest during...
Brighthouse Financial, Inc. (NASDAQ:BHFAM) Short Interest Up 127.4% in September
Brighthouse Financial, Inc. (NASDAQ:BHFAM – Get Free Report) was the recipient of a large growth in short interest in the...
Abeona Therapeutics (NASDAQ:ABEO) Share Price Crosses Above 50-Day Moving Average – What’s Next?
Abeona Therapeutics Inc (NASDAQ:ABEO – Get Free Report)’s stock price crossed above its 50 day moving average during trading on...
Accord Financial (TSE:ACD) Stock Price Crosses Below Two Hundred Day Moving Average – Should You Sell?
Accord Financial Corp. (TSE:ACD – Get Free Report)’s stock price passed below its 200-day moving average during trading on Thursday...
ROHM (OTCMKTS:ROHCY) Stock Price Passes Above Fifty Day Moving Average – What’s Next?
ROHM Co., Ltd. (OTCMKTS:ROHCY – Get Free Report)’s stock price passed above its 50 day moving average during trading on...